Literature DB >> 1480798

Comparison of the dependence of the TD50 on maximum tolerated dose for mutagens and nonmutagens.

G Goodman1, R Wilson.   

Abstract

The relationship between the minimum TD50 (i.e., the TD50 measured at the most sensitive site) and the maximum dose administered (maxD) in rodent carcinogenicity bioassays was investigated separately for mice and rats. The relationship between log(1/TD50) and log(1/maxD) was analyzed as a function of (1) mutagenicity and (2) the statistical significance cutoff for selecting the minimum TD50 values. For rat bioassays, the variance of log(1/TD50) is larger and the correlation of log(1/TD50) with log(1/maxD) is weaker for mutagens than for nonmutagens, suggesting that the relationship between minimum TD50 and MTD is, in general, stronger for nonmutagens than for mutagens. The difference in correlation does not depend on the TD50 statistical significance cutoff, but the difference in variance is not significant for the most stringently selected dataset. For mouse bioassays, no significant mutagen/nonmutagen differences in log(1/TD50) variance are found. A significantly weaker correlation of log(1/TD50) with log(1/maxD) for mutagens in comparison to nonmutagens occurs only for the dataset with minimum TD50 chosen at the least stringent level, suggesting that this difference may be due to chance variation. We also looked for changes in correlation and regression parameters as a function of mutagenic potency in Salmonella; the variance of log(1/TD50) and its correlation with log(1/maxD) are not found to vary in a consistent manner. Taken as a whole, our results indicate that (1) mutagenicity is a determinant of the TD50/maxD relationship in rats and (2) any effect that mutagenicity may exert on the TD50/maxD relationship in mice is unimportant.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1480798     DOI: 10.1111/j.1539-6924.1992.tb00709.x

Source DB:  PubMed          Journal:  Risk Anal        ISSN: 0272-4332            Impact factor:   4.000


  8 in total

1.  1,3,4-Oxadiazole-naphthalene hybrids as potential VEGFR-2 inhibitors: design, synthesis, antiproliferative activity, apoptotic effect, and in silico studies.

Authors:  Mohamed Hagras; Marwa A Saleh; Rogy R Ezz Eldin; Abdelrahman A Abuelkhir; Emad Gamil Khidr; Ahmed A El-Husseiny; Hesham A El-Mahdy; Eslam B Elkaeed; Ibrahim H Eissa
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.051

2.  Characterization, in-silico, and in-vitro study of a new steroid derivative from Ophiocoma dentata as a potential treatment for COVID-19.

Authors:  Mohamed S M Abd El Hafez; Miral G AbdEl-Wahab; Mohamed G Seadawy; Mostafa F El-Hosseny; Osama Beskales; Ali Saber Ali Abdel-Hamid; Maha A El Demellawy; Doaa A Ghareeb
Journal:  Sci Rep       Date:  2022-04-07       Impact factor: 4.379

3.  Identification, isolation, structural characterization, in silico toxicity prediction and in vitro cytotoxicity assay of simeprevir acidic and oxidative degradation products.

Authors:  Rasha M Ahmed; Marwa A A Fayed; Mohammed F El-Behairy; Inas A Abdallah
Journal:  RSC Adv       Date:  2020-11-24       Impact factor: 4.036

4.  The Inhibitory Potential of 2'-dihalo Ribonucleotides against HCV: Molecular Docking, Molecular Simulations, MM-BPSA, and DFT Studies.

Authors:  Ahmed Khalil; Amany S El-Khouly; Eslam B Elkaeed; Ibrahim H Eissa
Journal:  Molecules       Date:  2022-07-15       Impact factor: 4.927

5.  Discovery of New VEGFR-2 Inhibitors: Design, Synthesis, Anti-Proliferative Evaluation, Docking, and MD Simulation Studies.

Authors:  Eslam B Elkaeed; Reda G Yousef; Mohamed M Khalifa; Albaraa Ibrahim; Ahmed B M Mehany; Ibraheem M M Gobaara; Bshra A Alsfouk; Wagdy M Eldehna; Ahmed M Metwaly; Ibrahim H Eissa; Mohamed Ayman El-Zahabi
Journal:  Molecules       Date:  2022-09-21       Impact factor: 4.927

6.  New views on the hypothesis of respiratory cancer risk from soluble nickel exposure; and reconsideration of this risk's historical sources in nickel refineries.

Authors:  Philip G Thornhill; Bruce R Conard; James G Heller
Journal:  J Occup Med Toxicol       Date:  2009-08-23       Impact factor: 2.646

7.  In Silico Studies of Some Isoflavonoids as Potential Candidates against COVID-19 Targeting Human ACE2 (hACE2) and Viral Main Protease (Mpro).

Authors:  Mohamed S Alesawy; Abdallah E Abdallah; Mohammed S Taghour; Eslam B Elkaeed; Ibrahim H Eissa; Ahmed M Metwaly
Journal:  Molecules       Date:  2021-05-10       Impact factor: 4.411

8.  Comprehensive Virtual Screening of the Antiviral Potentialities of Marine Polycyclic Guanidine Alkaloids against SARS-CoV-2 (COVID-19).

Authors:  Amr El-Demerdash; Ahmed M Metwaly; Afnan Hassan; Tarek Mohamed Abd El-Aziz; Eslam B Elkaeed; Ibrahim H Eissa; Reem K Arafa; James D Stockand
Journal:  Biomolecules       Date:  2021-03-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.